TP53 and renal cell carcinoma: In investigations of RCC, the decrease in mitochondrial calcium uniporter (MCU) expression results in decreased ATP synthesis and AMPK activation, leading to decreased mitochondrial calcium uptake and degradation of p53, ultimately promoting cell proliferation [32].